Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Samsung Bioepis Co., Ltd.
Sort By
Newest First
Sign in
1 / 1
1 / 1
Investment
Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery
Samsung Biologics
PR-12-24-NI-141
Dec 18, 2024
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Pharma's Almanac
PAO-06-022--RT-01
Jun 24, 2022
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01
Jun 24, 2022
M&A
Samsung Biologics Reaches Agreement With Biogen to Acquire Full Ownership of Samsung Bioepis
Samsung Biologics
PR-M01-22-21
Jan 28, 2022
Biosimilar
FDA Approves Samsung Bioepis' HADLIMA™ (adalimumab-bwwd)
Samsung Bioepis
PA2329
Jul 26, 2019
Phase I
Samsung Bioepis to Initiate Phase 1 Clinical Trial of SB26 Ulinastatin-Fc Fusion Protein
Samsung Bioepis
PR-M09-18-NI-007
Sep 05, 2018
Partnership
Samsung to Develop Novel Drugs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M09-17-NI-002
Sep 01, 2017
Partnership
Collaboration Seeks Novel Pancreatitis Therapies
Nice Insight
PAO-M08-17-NI-037
Aug 29, 2017
